Compile Data Set for Download or QSAR
maximum 50k data
Found 84 of ic50 for UniProtKB: P03367
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126682(US8785638, 170)
Affinity DataIC50:  50nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126676(US8785638, 161)
Affinity DataIC50:  55.4nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM98672(US8497270, 35)
Affinity DataIC50:  200nMAssay Description:Inhibition of HIV integrase.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM98668(US8497270, 29)
Affinity DataIC50:  250nMAssay Description:Inhibition of HIV integrase.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM98669(US8497270, 30)
Affinity DataIC50:  360nMAssay Description:Inhibition of HIV integrase.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126692(US8785638, 190)
Affinity DataIC50:  370nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126690(US8785638, 186)
Affinity DataIC50:  430nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126634(US8785638, 116)
Affinity DataIC50:  620nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126631(US8785638, 113 | US8785638, 142)
Affinity DataIC50:  750nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126635(US8785638, 117)
Affinity DataIC50:  780nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM98665(US8497270, 24)
Affinity DataIC50:  950nMAssay Description:Inhibition of HIV integrase.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM98667(US8497270, 28)
Affinity DataIC50:  1.00E+3nMAssay Description:Inhibition of HIV integrase.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126632(US8785638, 114)
Affinity DataIC50: <1.00E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126679(US8785638, 165)
Affinity DataIC50: <1.00E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126685(US8785638, 175)
Affinity DataIC50: <1.00E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126630(US8785638, 112)
Affinity DataIC50:  1.11E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM98670(US8497270, 31)
Affinity DataIC50:  1.20E+3nMAssay Description:Inhibition of HIV integrase.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126683(US8785638, 171)
Affinity DataIC50:  1.21E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126666(US8785638, 150)
Affinity DataIC50:  1.37E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126677(US8785638, 162)
Affinity DataIC50:  1.57E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM98671(US8497270, 32)
Affinity DataIC50:  1.60E+3nMAssay Description:Inhibition of HIV integrase.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126664(US8785638, 148)
Affinity DataIC50:  2.19E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM97447(Aspartyl protease inhibitor, 13)
Affinity DataIC50:  2.20E+3nMpH: 5.5Assay Description:Binding constants for inhibition of HIV protease were determined as previously described.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126637(US8785638, 119)
Affinity DataIC50:  2.66E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126638(US8785638, 120)
Affinity DataIC50:  2.72E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126643(US8785638, 127)
Affinity DataIC50:  2.85E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126680(US8785638, 166)
Affinity DataIC50:  3.00E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126639(US8785638, 122)
Affinity DataIC50:  3.20E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM97448(Aspartyl protease inhibitor, 14)
Affinity DataIC50:  3.30E+3nMpH: 5.5Assay Description:Binding constants for inhibition of HIV protease were determined as previously described.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126689(US8785638, 184)
Affinity DataIC50:  3.44E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126629(US8785638, 110)
Affinity DataIC50:  4.31E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126652(US8785638, 136)
Affinity DataIC50:  4.34E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126627(US8785638, 108)
Affinity DataIC50:  4.48E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126678(US8785638, 163)
Affinity DataIC50:  4.50E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126647(US8785638, 131)
Affinity DataIC50:  4.54E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126662(US8785638, 146)
Affinity DataIC50:  4.76E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126684(US8785638, 173)
Affinity DataIC50:  5.90E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126622(US8785638, 100)
Affinity DataIC50:  6.61E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126660(US8785638, 144)
Affinity DataIC50:  6.64E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126628(US8785638, 109)
Affinity DataIC50:  6.81E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126631(US8785638, 113 | US8785638, 142)
Affinity DataIC50:  7.43E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126649(US8785638, 133)
Affinity DataIC50:  7.80E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126687(US8785638, 181)
Affinity DataIC50:  8.06E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126669(US8785638, 154)
Affinity DataIC50:  8.12E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126655(US8785638, 139)
Affinity DataIC50:  9.24E+3nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126644(US8785638, 128)
Affinity DataIC50:  1.13E+4nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126686(US8785638, 177)
Affinity DataIC50:  1.17E+4nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM97449(Aspartyl protease inhibitor, 15)
Affinity DataIC50:  1.21E+4nMpH: 5.5Assay Description:Binding constants for inhibition of HIV protease were determined as previously described.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126674(US8785638, 159)
Affinity DataIC50:  1.33E+4nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Katholieke Universiteit Leuven

US Patent
LigandPNGBDBM126673(US8785638, 158)
Affinity DataIC50:  1.35E+4nMpH: 7.4 T: 2°CAssay Description:The AlphaScreen assay was performed according to the manufacturer's protocol (Perkin Elmer, Benelux). Reactions were performed in 25 ul final volume ...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 84 total ) | Next | Last >>
Jump to: